Richard C. Woodman
Directeur/Bestuurslid bij H3 Biomedicine, Inc.
Actieve functies van Richard C. Woodman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Directeur/Bestuurslid | 11-01-2022 | - |
Loopbaan van Richard C. Woodman
Eerdere bekende functies van Richard C. Woodman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TRAWS PHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 07-11-2018 | 15-01-2021 |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Hoofd Techniek/Wetenschap/O&O | 01-01-2006 | 01-03-2018 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01-01-2002 | 01-01-2006 |
| EISAI CO., LTD. | Corporate Officer/Principal | - | - |
| University of Calgary | Corporate Officer/Principal | 01-01-1990 | - |
Opleiding van Richard C. Woodman
| University of Calgary | Doctorate Degree |
| University of British Columbia | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Canada | 3 |
| Japan | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| EISAI CO., LTD. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Health Technology |
- Beurs
- Insiders
- Richard C. Woodman
- Ervaring
